Release Date: 30/01/14 10:32 Summary: Company Secretary Appointment/Resignation Price Sensitive: No Download Document 315.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%